Titan Medical and Teleflex Announce Collaboration to Develop Robotic Ligation Tech
Posted on March 26, 2019 by Medtech[y] Staff
In preparation of the anticipated approval and commercialization of the SPORT Surgical System in 2020, Titan Medical announced a collaboration with Teleflex in which their polymer ligation technology will be integrated into the SPORT single-port robotic surgery system. Teleflex’s Weck Hem-o-lok polymer ligation system is a ligation technology for vessel sealing with enhanced clip security features.
In January 2019, Titan Medical provided an updated regulatory timeline, sharing that the company intends on filing their 510(k) submission and CE Mark for the SPORT Surgical System by the end of the year.
David McNally, President and CEO of Titan Medical, said, “Our patented, multi-articulating instruments have been developed to facilitate the integration of advanced tools and technologies. This collaboration with Teleflex permits the expansion of our robotic instrument portfolio to offer market-leading, proven technology in a variety of surgical disciplines. Teleflex is a leading and innovative medical technology company with whom we share a common purpose of improving patient outcomes with clinically-inspired technology. We are proud to be working with them.”
Titan Medical Next-Generation Single Port Surgical System Enhancement
In support of filing their 510(k), Titan plans to complete the required human confirmatory studies under an Investigational Device Exemption during the second half of 2019 and they intend on commercializing the single-port robotic system in the U.S. and Europe in 2020.
James Ferguson, President and General Manager of the Surgical Division of Teleflex, said, “We continue to partner with leading robotic companies to allow surgeons globally to use our trusted Weck ligation solutions. We are excited about Titan Medical integrating our technology into its single-port robotic surgery system.”
One would expect Titan to continue developing partners as they get closer to regulatory approval in order to maximize their reach when building their capital sales pipeline. Having other companies and their salesforce working to educate the surgical community about the SPORT Surgical System will be necessary to compete with companies like Intuitive Surgical and upstarts like TransEnterix and their Senhance System.